Procter & Gamble Health Limited has informed the Exchange about General Updates
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE and NSE have approved Procter & Gamble Health's application (originally filed on June 27, 2018) to reclassify three erstwhile promoter entities — Emedia Export Company, Chemitra Gesellschaft, and Merck Internationale Beteiligungen GmbH — from 'promoter' category to 'public shareholders.' The reclassification is effective December 3, 2018. After this change, Procter & Gamble Overseas India BV remains the sole promoter with a 51.82% stake, while public shareholders collectively hold 48.18% of the company. No actual transfer or sale of shares has occurred — only a change in shareholding classification for disclosure purposes.
There is no change in actual ownership or control; this is purely a regulatory reclassification. P&G Overseas India BV continues to hold a comfortable majority above 50%, so the company's control structure remains unchanged. Existing shareholders should not expect any impact on dividend rights, voting power, or stock price from this disclosure.